A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania
暂无分享,去创建一个
V. Usonis | P. Wright | R. Connor | W. Weldon | E. Brickley | W. Wieland-Alter | M. Ackerman | A. Bandyopadhyay | M. Oberste | Chris Gast | R. Rüttimann | R. Clemens
[1] O. Diop,et al. Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2020–June 2021 , 2021, MMWR. Morbidity and mortality weekly report.
[2] O. Diop,et al. Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, July 2019–February 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[3] J. Weiner,et al. Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden , 2019, BMJ Global Health.
[4] John O. Konz,et al. The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study , 2019, The Lancet.
[5] J. Modlin,et al. Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] P. Wright,et al. Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine–only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] D. Grobbee,et al. The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] M. Pallansch,et al. Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial. , 2018, The Lancet. Infectious diseases.
[9] J. Weiner,et al. Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine , 2018, The Journal of infectious diseases.
[10] Lerato Seakamela,et al. Diagnostic Assay Development for Poliovirus Eradication , 2017, Journal of Clinical Microbiology.
[11] P. Wright,et al. Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants , 2016, The Lancet. Infectious diseases.
[12] N. Grassly,et al. Unravelling mucosal immunity to poliovirus. , 2016, The Lancet. Infectious diseases.
[13] L. Hampton,et al. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016. , 2016, MMWR. Morbidity and mortality weekly report.
[14] M. Pallansch,et al. Standardized Methods for Detection of Poliovirus Antibodies. , 2016, Methods in molecular biology.
[15] Walter A Orenstein,et al. Polio vaccination: past, present and future. , 2015, Future microbiology.
[16] M. Pallansch,et al. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination. , 2014, The Journal of infectious diseases.
[17] N. Grassly,et al. Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus Challenge , 2012, PLoS pathogens.
[18] T. Wakita,et al. Development of a Poliovirus Neutralization Test with Poliovirus Pseudovirus for Measurement of Neutralizing Antibody Titer in Human Serum , 2011, Clinical and Vaccine Immunology.
[19] R. Sutter,et al. Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial , 2010, The Lancet.
[20] A. Vincent,et al. Rapid Group-, Serotype-, and Vaccine Strain-Specific Identification of Poliovirus Isolates by Real-Time Reverse Transcription-PCR Using Degenerate Primers and Probes Containing Deoxyinosine Residues , 2009, Journal of Clinical Microbiology.
[21] David Heymann. Global polio eradication initiative. , 2006, Bulletin of the World Health Organization.
[22] R. Sutter,et al. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.